South Africa's drugs regulator SAHPRA said on Wednesday that it had recently reviewed data from Johnson & Johnson's (J&J) local research study immunising healthcare workers and found no major safety concerns.

{{^htLoading}} {{/htLoading}}
SAHPRA added that it was awaiting additional data from J&J and the US Food and Drug Administration.
Advertisement
{{/htLoading}}Suggested For You
South Africa suspended the rollout of the J&J vaccine in the "implementation study" on Tuesday, after US health agencies recommended pausing its use because of rare cases of blood clots in six people inoculated with it.
Explore More
ABOUT THE AUTHOR
Online journalist based in New Delhi. I read about global conflicts and the drug war in Mexico.
Get the latest World News, breaking headlines, and real-time coverage from key global hotspots, including the US News, Russia, Ukraine, Iran News, and the UAE News. Track developing conflicts, high-stakes diplomacy, and major international events on Hindustan Times.
Get the latest World News, breaking headlines, and real-time coverage from key global hotspots, including the US News, Russia, Ukraine, Iran News, and the UAE News. Track developing conflicts, high-stakes diplomacy, and major international events on Hindustan Times.
Advertisement
{{/htLoading}}{{#usCountry}} {{/usCountry}}